Related Experiment Video
Updated: Jul 9, 2026
Mistletoe Eradicator - A Novel Tool for Simultaneous Mechanical and Chemical Control of Mistletoe
Published on: March 1, 2022
Isolation and characterization of two Korean mistletoe lectins
Tae Bong Kang1, Seong Kyu Song, Taek Joon Yoon
1School of Food and Biosciences, Handong Global University, Pohang 791-940, Korea.
Insights
Researchers isolated two Korean mistletoe lectin isolectins, KML-IIU and KML-IIL, revealing significant differences in their anti-cancer properties. KML-IIL exhibits stronger cytotoxicity and cytokine induction, suggesting its potential as an anti-cancer therapeutic agent.
Area of Science:
- Biochemistry
- Immunology
- Pharmacology
Background:
- Korean mistletoe lectin (KML-C) is a known bioactive compound.
- Lectins are proteins with specific carbohydrate-binding properties.
- Understanding isolectin variations is crucial for therapeutic development.
Purpose of the Study:
- To isolate and characterize two distinct isolectins from KML-C: KML-IIU and KML-IIL.
- To compare the biophysical properties and bioactivities of KML-IIU and KML-IIL.
- To evaluate the potential of these isolectins as anti-cancer agents.
Main Methods:
- Immunoaffinity chromatography was used for isolectin isolation.
- Molecular weights were determined.
- Carbohydrate-binding specificities were assessed.
- Cytotoxicity assays were performed on various cancer cell lines.
- Tumor necrosis factor-alpha (TNF-alpha) secretion was measured in macrophages.
Main Results:
- Two isolectins, KML-IIU (64 kDa) and KML-IIL (60 kDa), were successfully isolated.
- Both isolectins bind to Gal and GalNAc but differ in glycosylation and amino acid composition.
- KML-IIL demonstrated significantly higher cytotoxicity (17-145 times) against cancer cells compared to KML-IIU.
- KML-IIL induced 4.5 times more TNF-alpha secretion from macrophages than KML-IIU.
Conclusions:
- Isolectins from Korean mistletoe exhibit distinct bioactivities.
- KML-IIL possesses superior cytotoxic and immune-stimulating properties compared to KML-IIU.
- KML-IIL shows promise as a potential anti-cancer therapeutic agent.
Abstract:
Two isolectins (KML-IIU and the KML-IIL) were individually isolated from the previously reported Korean mistletoe lectin, KML-C, by using an immunoaffinity column. Molecular weights of the KML-IIU and the KML-IIL were 64 kDa and 60 kDa respectively. Both of the lectins were composed of heterogeneous A and B subunits linked with a disulfide bond, and showed the same carbohydrate-binding specificities for Gal and GalNAc. However, they are different not only in biophysical properties (glycosylation and amino acid compositions) but also bioactivities (cell killing and cytokine induction). The KML-IIL showed 17-145 times stronger in cytotoxicities to various human and mouse cancer cell lines than the KML-IIU. The KML-IIL also induced TNF-alpha secretion from mouse peritoneal macrophages 4.5 times better than the KML-IIU. The results demonstrated isolectins in Korean mistletoe were varied in bioactivities and the KML-IIL may be developed as an anti-cancer agent.
